Cargando…

Commentary: Current Status of Gene Therapy for Spinal Muscular Atrophy

Detalles Bibliográficos
Autores principales:	Rossoll, Wilfried, Singh, Ravindra N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cellular Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9152110/ https://www.ncbi.nlm.nih.gov/pubmed/35656408 http://dx.doi.org/10.3389/fncel.2022.916065

Ejemplares similares

Editorial: Advances in spinal muscular atrophy
por: Sun, Jianli
Publicado: (2023)

SMN post-translational modifications in spinal muscular atrophy
por: Riboldi, Giulietta M., et al.
Publicado: (2023)

History of development of the life-saving drug “Nusinersen” in spinal muscular atrophy
por: Qiu, Jiaying, et al.
Publicado: (2022)

The alteration of left ventricular strain in later-onset spinal muscular atrophy children
por: Cui, Yiqin, et al.
Publicado: (2022)

R-loop Mediated DNA Damage and Impaired DNA Repair in Spinal Muscular Atrophy
por: Cuartas, Juliana, et al.
Publicado: (2022)

Corrigendum: The alteration of left ventricular strain in later-onset spinal muscular atrophy children
por: Cui, Yiqin, et al.
Publicado: (2022)

NADPH oxidase 4 inhibition is a complementary therapeutic strategy for spinal muscular atrophy
por: El Khoury, Mirella, et al.
Publicado: (2023)

Spinal Muscular Atrophy Type IIIb Complicated by Moyamoya Syndrome: A Case Report and Literature Review
por: Li, Jing, et al.
Publicado: (2022)

Survival motor neuron protein and neurite degeneration are regulated by Gemin3 in spinal muscular atrophy motoneurons
por: Miralles, Maria P., et al.
Publicado: (2022)

Current Status of Treatment of Spinal and Bulbar Muscular Atrophy
por: Tanaka, Fumiaki, et al.
Publicado: (2012)

A homozygous missense variant in the YG box domain in an individual with severe spinal muscular atrophy: a case report and variant characterization
por: Li, Leping, et al.
Publicado: (2023)

Motor Neuron Gene Therapy: Lessons from Spinal Muscular Atrophy for Amyotrophic Lateral Sclerosis
por: Tosolini, Andrew P., et al.
Publicado: (2017)

Smn, the spinal muscular atrophy–determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons
por: Rossoll, Wilfried, et al.
Publicado: (2003)

The role of ubiquitination in spinal and bulbar muscular atrophy
por: Sengupta, Medha, et al.
Publicado: (2022)

Structural Context of a Critical Exon of Spinal Muscular Atrophy Gene
por: Singh, Natalia N., et al.
Publicado: (2022)

Comprehensive Modeling of Spinal Muscular Atrophy in Drosophila melanogaster
por: Spring, Ashlyn M., et al.
Publicado: (2019)

Increasing Agrin Function Antagonizes Muscle Atrophy and Motor Impairment in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2018)

The First Orally Deliverable Small Molecule for the Treatment of Spinal Muscular Atrophy
por: Singh, Ravindra N, et al.
Publicado: (2020)

Overview of Current Drugs and Molecules in Development for Spinal Muscular Atrophy Therapy
por: Shorrock, Hannah K., et al.
Publicado: (2018)

Gene therapy for spinal muscular atrophy: the Qatari experience
por: Ali, Hossamaldein Gaber, et al.
Publicado: (2021)

Modulating role of RNA structure in alternative splicing of a critical exon in the spinal muscular atrophy genes
por: Singh, Natalia N., et al.
Publicado: (2007)

Neuromuscular Junctions as Key Contributors and Therapeutic Targets in Spinal Muscular Atrophy
por: Boido, Marina, et al.
Publicado: (2016)

Oxidative Stress Triggers Body-Wide Skipping of Multiple Exons of the Spinal Muscular Atrophy Gene
por: Seo, Joonbae, et al.
Publicado: (2016)

Internal Introns Promote Backsplicing to Generate Circular RNAs from Spinal Muscular Atrophy Gene
por: Luo, Diou, et al.
Publicado: (2022)

Commentary: Large Acid-Evoked Currents, Mediated by ASIC1a, Accompany Differentiation in Human Dopaminergic Neurons
por: William, Matthew, et al.
Publicado: (2021)

Spinal muscular atrophy
por: D'Amico, Adele, et al.
Publicado: (2011)

Exploring the Role of Posttranslational Modifications in Spinal and Bulbar Muscular Atrophy
por: Gogia, Neha, et al.
Publicado: (2022)

Proximal spinal muscular atrophy: current orthopedic perspective
por: Haaker, Gerrit, et al.
Publicado: (2013)

Current and emerging treatment options for spinal muscular atrophy
por: Farooq, Faraz, et al.
Publicado: (2015)

Gene therapy for spinal muscular atrophy: the benefit–cost profile
Publicado: (2021)

Clinical Commentary: Obstetric and Respiratory Management of Pregnancy with Severe Spinal Muscular Atrophy
por: Flunt, Daniel, et al.
Publicado: (2009)

Nemo-like kinase is a novel regulator of spinal and bulbar muscular atrophy
por: Todd, Tiffany W, et al.
Publicado: (2015)

Emerging therapies and challenges in spinal muscular atrophy
por: Farrar, Michelle A., et al.
Publicado: (2017)

Splice-Switching Therapy for Spinal Muscular Atrophy
por: Meijboom, Katharina E., et al.
Publicado: (2017)

Neuronal involvement in muscular atrophy
por: Cisterna, Bruno A., et al.
Publicado: (2014)

A Multi-Exon-Skipping Detection Assay Reveals Surprising Diversity of Splice Isoforms of Spinal Muscular Atrophy Genes
por: Singh, Natalia N., et al.
Publicado: (2012)

Management and current status of spinal muscular atrophy: a retrospective multicentre claims database analysis
por: Darbà, Josep
Publicado: (2020)

Gene therapy for spinal muscular atrophy: Solomon's consensus in Covid times
por: Zafeiriou, Dimitrios
Publicado: (2020)

Risdiplam for spinal muscular atrophy
Publicado: (2022)

Nusinersen for spinal muscular atrophy
por: Wurster, Claudia D., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_h1lpbq5o6dhghc8de47stcjb60